TY - JOUR
T1 - Blood-brain barrier
T2 - Structural components and function under physiologic and pathologic conditions
AU - Persidsky, Yuri
AU - Ramirez, Servio H.
AU - Haorah, James
AU - Kanmogne, Georgette D.
N1 - Funding Information:
Acknowledgements We thank Ms. Robin Taylor and Ms. Debra Baer for excellent administrative support. The NIH National Neuro-AIDS Consortium and the CNND brain bank are acknowledged for brain tissue specimens used in this study. This work was supported in part by research grants by the National Institutes of Health: PO1 NS043985, RO1 AA015913, and RO1 MH65151 (Y.P.).
PY - 2006/9
Y1 - 2006/9
N2 - The blood-brain barrier (BBB) is the specialized system of brain microvascular endothelial cells (BMVEC) that shields the brain from toxic substances in the blood, supplies brain tissues with nutrients, and filters harmful compounds from the brain back to the bloodstream. The close interaction between BMVEC and other components of the neurovascular unit (astrocytes, pericytes, neurons, and basement membrane) ensures proper function of the central nervous system (CNS). Transport across the BBB is strictly limited through both physical (tight junctions) and metabolic barriers (enzymes, diverse transport systems). A functional polarity exists between the luminal and abluminal membrane surfaces of the BMVEC. As a result of restricted permeability, the BBB is a limiting factor for the delivery of therapeutic agents into the CNS. BBB breakdown or alterations in transport systems play an important role in the pathogenesis of many CNS diseases (HIV-1 encephalitis, Alzheimer's disease, ischemia, tumors, multiple sclerosis, and Parkinson's disease). Proinflammatory substances and specific disease-associated proteins often mediate such BBB dysfunction. Despite seemingly diverse underlying causes of BBB dysfunction, common intracellular pathways emerge for the regulation of the BBB structural and functional integrity. Better understanding of tight junction regulation and factors affecting transport systems will allow the development of therapeutics to improve the BBB function in health and disease.
AB - The blood-brain barrier (BBB) is the specialized system of brain microvascular endothelial cells (BMVEC) that shields the brain from toxic substances in the blood, supplies brain tissues with nutrients, and filters harmful compounds from the brain back to the bloodstream. The close interaction between BMVEC and other components of the neurovascular unit (astrocytes, pericytes, neurons, and basement membrane) ensures proper function of the central nervous system (CNS). Transport across the BBB is strictly limited through both physical (tight junctions) and metabolic barriers (enzymes, diverse transport systems). A functional polarity exists between the luminal and abluminal membrane surfaces of the BMVEC. As a result of restricted permeability, the BBB is a limiting factor for the delivery of therapeutic agents into the CNS. BBB breakdown or alterations in transport systems play an important role in the pathogenesis of many CNS diseases (HIV-1 encephalitis, Alzheimer's disease, ischemia, tumors, multiple sclerosis, and Parkinson's disease). Proinflammatory substances and specific disease-associated proteins often mediate such BBB dysfunction. Despite seemingly diverse underlying causes of BBB dysfunction, common intracellular pathways emerge for the regulation of the BBB structural and functional integrity. Better understanding of tight junction regulation and factors affecting transport systems will allow the development of therapeutics to improve the BBB function in health and disease.
KW - Blood-brain barrier
KW - Leukocyte migration
KW - Multidrug resistance proteins
KW - Neurovascular unit
KW - Tight junctions
UR - http://www.scopus.com/inward/record.url?scp=33747368249&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33747368249&partnerID=8YFLogxK
U2 - 10.1007/s11481-006-9025-3
DO - 10.1007/s11481-006-9025-3
M3 - Article
C2 - 18040800
AN - SCOPUS:33747368249
SN - 1557-1890
VL - 1
SP - 223
EP - 236
JO - Journal of Neuroimmune Pharmacology
JF - Journal of Neuroimmune Pharmacology
IS - 3
ER -